Aqr Capital Management LLC Anavex Life Sciences Corp. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Aqr Capital Management LLC holds 136,644 shares of AVXL stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,644

Previous 45,219 202.18%

Holding current value

$1.02 Million

Previous $190,000 308.42%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.11 - $7.04 $375,756 - $643,632	91,425 Added 202.18%	136,644 $776,000
Q2 2024 Aug 14, 2024	BUY	$3.39 - $5.02 $90,923 - $134,641	26,821 Added 145.78%	45,219 $190,000
Q1 2024 May 15, 2024	SELL	$4.55 - $6.75 $923 - $1,370	-203 Reduced 1.09%	18,398 $93,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $9,117 - $17,999	1,809 Added 10.77%	18,601 $173,000
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $22,656 - $32,410	3,459 Added 25.94%	16,792 $109,000
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $6,832 - $8,474	892 Added 7.17%	13,333 $108,000
Q1 2023 May 15, 2023	SELL	$8.32 - $11.75 $107,635 - $152,009	-12,937 Reduced 50.98%	12,441 $106,000
Q4 2022 Feb 14, 2023	SELL	$7.65 - $14.43 $3,006 - $5,670	-393 Reduced 1.52%	25,378 $235,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $13,074 - $18,891	1,469 Added 6.04%	25,771 $266,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $30,095 - $52,862	-4,117 Reduced 14.49%	24,302 $243,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $78,514 - $142,599	-8,061 Reduced 22.1%	28,419 $350,000
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $98,815 - $136,456	5,854 Added 19.11%	36,480 $633,000
Q3 2021 Nov 15, 2021	BUY	$16.82 - $25.75 $24,069 - $36,848	1,431 Added 4.9%	30,626 $550,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $7,884 - $22,395	776 Added 2.73%	29,195 $667,000
Q1 2021 May 17, 2021	SELL	$5.17 - $16.13 $57,971 - $180,865	-11,213 Reduced 28.29%	28,419 $425,000
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $6,792 - $12,840	1,694 Added 4.47%	39,632 $214,000
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $7,307 - $9,615	1,923 Added 5.34%	37,938 $173,000
Q2 2020 Aug 17, 2020	BUY	$2.62 - $5.2 $40,494 - $80,371	15,456 Added 75.18%	36,015 $177,000
Q1 2020 May 15, 2020	BUY	$2.38 - $5.81 $48,930 - $119,447	20,559 New	20,559 $65,000

Others Institutions Holding AVXL

# of Institutions

154

Shares Held

27.3M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $581M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Anavex Life Sciences Corp. Transaction History